Sanofi SA (SNY)
48.02
+0.24
(+0.50%)
USD |
NASDAQ |
Nov 21, 14:08
Sanofi Price to Book Value: 1.545 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 1.537 |
| November 19, 2024 | 1.544 |
| November 18, 2024 | 1.561 |
| November 15, 2024 | 1.544 |
| November 14, 2024 | 1.539 |
| November 13, 2024 | 1.593 |
| November 12, 2024 | 1.613 |
| November 11, 2024 | 1.629 |
| November 08, 2024 | 1.651 |
| November 07, 2024 | 1.664 |
| November 06, 2024 | 1.649 |
| November 05, 2024 | 1.701 |
| November 04, 2024 | 1.704 |
| November 01, 2024 | 1.714 |
| October 31, 2024 | 1.702 |
| October 30, 2024 | 1.720 |
| October 29, 2024 | 1.732 |
| October 28, 2024 | 1.749 |
| October 25, 2024 | 1.748 |
| October 24, 2024 | 1.675 |
| October 23, 2024 | 1.702 |
| October 22, 2024 | 1.714 |
| October 21, 2024 | 1.727 |
| October 18, 2024 | 1.768 |
| October 17, 2024 | 1.765 |
| Date | Value |
|---|---|
| October 16, 2024 | 1.752 |
| October 15, 2024 | 1.756 |
| October 14, 2024 | 1.767 |
| October 11, 2024 | 1.768 |
| October 10, 2024 | 1.762 |
| October 09, 2024 | 1.775 |
| October 08, 2024 | 1.765 |
| October 07, 2024 | 1.762 |
| October 04, 2024 | 1.785 |
| October 03, 2024 | 1.787 |
| October 02, 2024 | 1.81 |
| October 01, 2024 | 1.844 |
| September 30, 2024 | 1.854 |
| September 27, 2024 | 1.855 |
| September 26, 2024 | 1.834 |
| September 25, 2024 | 1.823 |
| September 24, 2024 | 1.854 |
| September 23, 2024 | 1.848 |
| September 20, 2024 | 1.854 |
| September 19, 2024 | 1.874 |
| September 18, 2024 | 1.849 |
| September 17, 2024 | 1.831 |
| September 16, 2024 | 1.844 |
| September 13, 2024 | 1.838 |
| September 12, 2024 | 1.826 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.260
Minimum
Sep 27 2022
1.990
Maximum
Jun 22 2020
1.668
Average
1.685
Median
Feb 03 2022
Price to Book Value Benchmarks
| AstraZeneca PLC | 4.859 |
| GSK PLC | 3.653 |
| Eli Lilly and Co | 49.99 |
| Novavax Inc | -- |
| Regeneron Pharmaceuticals Inc | 2.810 |
Price to Book Value Related Metrics
| PE Ratio | 24.33 |
| PS Ratio | 2.266 |
| Price | 48.02 |
| Earnings Yield | 4.11% |
| Market Cap | 120.39B |
| Operating PE Ratio | 10.47 |
| Normalized PE Ratio | 14.99 |